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Abstract 
For almost a decade, mesenchymal stem cells (MSCs) were believed to reside as 
perivascular cells in vivo. In this issue, Guimarães-Camboa et al. challenge this 
idea, and use lineage tracing to demonstrate that perivascular cells do not 
behave as tissue-specific progenitors in various organs, despite showing MSC 
potential in vitro. 
 
Main Text 
Mesenchymal stem cells (MSCs) have attracted considerable attention as 
promising tools for cell-based regenerative therapies. The prospect of being able 
to transplant, or even reactivate in situ, tissue-resident progenitors evokes great 
interest, particularly as alternative strategies, such as the use of induced 
pluripotent stem cells, prove increasingly challenging. However, little is 
currently known about the biology of such progenitors in their native 
microenvironment, and the nature and functions of MSCs in vivo remain unclear. 
In this issue of Cell Stem Cell, Guimarães-Camboa and colleagues provide new 
insights into the identity of these cells, and challenge the previous idea that they 
may correspond to perivascular cells in vivo. 
 
Strictly, the term MSC refers to a sub-population of cells in the bone marrow 
(BM) that was found to be able to regenerate the BM stroma and its environment 
upon serial transplantation (Sacchetti et al., 2007). When grown in vitro, BM-
MSCs behave as adherent, colony-forming cells with the ability to differentiate 
into all skeletal tissue lineages (chondrocytes, osteoblasts and adipocytes). Cells 
exhibiting the same characteristics as BM-MSCs in vitro have been extracted 
from many organs, leading to the hypothesis that MSCs exist in most tissues 
where they can participate in both tissue homeostasis and repair. When isolated 
and reintroduced in vivo, these cells contribute to multiple lineages. However, 
their ability to self-renew and differentiate into tissue-specific lineages within 
their endogenous environment, without any experimental manipulation, was not 
consistently proven, raising an ongoing and heated debate about their definition 
as MSCs, given that the term is restricted to native in vivo populations (Bianco, 
2014). In 2008, Crisan and colleagues made a prominent advance towards the 
identification of MSCs in vivo, by finding that perivascular/mural cells, i.e. 
pericytes and vascular smooth muscle cells (vSMCs), extracted from several 
human tissues behave as MSCs in vitro and upon transplantation in vivo, while 
expressing MSC markers as shown by histological analysis (Crisan et al., 2008). 
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Since then, it was postulated that perivascular cells behave as MSCs in vivo. 
Further studies supported this model, showing that transplanted purified 
perivascular cells (Chen et al., 2015; Dellavalle et al., 2007) and, more 
importantly, genetically-traced pericytes and vSMCs (Feng et al., 2011; Goritz et 
al., 2011; Krautler et al., 2012; Tang et al., 2008) contribute to tissue-specific 
lineages in vivo. 
 
In the current issue, Guimarães-Camboa and colleagues now challenge this 
concept and suggest that mural cells do not intrinsically behave as MSCs during 
aging and repair in multiple adult organs. Their work relies on the identification 
of Tbx18 as a gene specifically expressed in all mural cells of many adult organs 
in the mouse, including the brain, heart, skeletal muscle, and brown and white 
adipose tissues. Using a transgenic line they generated expressing an inducible 
Cre recombinase in Tbx18-expressing cells (Tbx18-CreERT2), they perform a 
tissue-wide lineage tracing study and follow the progeny of pericytes and vSMCs 
during both aging and post-injury tissue repair. Surprisingly, they find that over 
the course of two years, Tbx18 lineage-derived cells maintain their perivascular 
identity in brain, heart, muscle and fat, therefore suggesting that mural cells do 
not exhibit overt potential to give rise to other cell types during aging in these 
organs. In order to test whether such potential could arise in the context of tissue 
repair, the authors genetically-traced Tbx18 lineage-derived cells following 
injury (brain, heart, muscle) or under strong adipogenic stimuli. In all cases, 
marked pericytes and vSMCs did not contribute to other tissue-specific cell 
types, thus strongly suggesting that mural cells do not behave as MSCs in the 
studied organs. 
 
This work raises important questions, both regarding the methods used to 
identify MSCs and to assess their potential in vivo, as well as about the biology of 
MSCs itself. Transplantation has been widely used as a technique to assess cell 
potency in vivo. However, discussions in the field have already suggested that the 
differentiation potential of transplanted cells could be affected by ex vivo 
manipulation, and cell-cell fusion events with host cells have also been reported. 
Genetic lineage tracing studies, on the other hand, offer the possibility to label 
cells and follow their progeny within their native microenvironment, and 
constitute the most reliable method to assess cell potency in vivo. However, the 
strategy of lineage tracing is highly dependent on the genetic tools at use. The 
discrepancies between the present work and previous studies may, therefore, 
mostly rely on the specificity of the transgenic lines used to mark mural cells in 
vivo. Notably, Guimarães-Camboa and colleagues show here that the PDGFRß-
Cre line, previously used to follow the progeny of mural cells in vivo (Krautler et 
al., 2012; Tang et al., 2008) is not suitable for this purpose as PDGFRß is 
expressed throughout the embryo and in adult organs within non-mural cell 
types. Other studies using mouse lines, however, do show contribution of 
perivascular cells to tissue-specific cell types during postnatal development 
(Feng et al., 2011) and in post-injury responses (Feng et al., 2011; Goritz et al., 
2011) with no reported lack of specificity. The divergence of their results with 
the present work may suggest that mural cells can behave as MSCs, but that this 
behavior is dependent on the organ and developmental stage. At present, it is 
clear that pericytes and vSMCs, best characterized by their morphology and 
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topology, are a highly heterogeneous population in terms of ontogeny, 
expression profiles and even cell type and functions. Therefore, mural cells may 
show different cellular potencies within different organs and with disparate  
developmental ages. With the advent of single cell technologies, the true 
heterogeneity and potential plasticity of perivascular cells will likely be revealed 
with much greater detail in the near future.  
 
This work also raises important questions regarding MSC biology. First, it 
challenges the previous established idea that MSCs identify as perivascular cells. 
However, since Guimarães-Camboa and colleagues label a very high percentage, 
but not all mural cells,  they may have overlooked the contribution of a small but 
nevertheless existing population of mural cells with progenitor properties. It also 
should be noted that the present conclusions rely on the use of antigen profiles 
defined by our current knowledge and understanding of mural cell identity, and 
that MSCs could constitute a subset of perivascular cells with distinct properties 
and markers. Finally, a major finding of this study is that cells possessing all the 
hallmarks of MSCs in vitro can lack any MSC potential in vivo. This finding puts 
into question much of the previous literature supporting the existence of multi-
lineage progenitors, such as MSCs, in many adult organs based on the 
transplantation of isolated cells, and challenges the existence of MSCs itself in 
those organs.  Further work will need to address this key issue, and assess the 
potential of putative MSCs in situ. As many clinical trials using MSCs as 
therapeutic agents are currently under way and show only limited success, the 
present study highlights a crucial need for a better definition and understanding 
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